Moreover, a proteomic study focusing on brain cortical specimens demonstrated significantly reduced levels of clavesin-2 and clavesin-1 proteins in AD patients compared to controls (P = 8.75E−03 and P = 8.64E−03, respectively) [20]. This evidence concerns the gene CLVS2 and Alzheimer disease.